Omeros Corporation (NASDAQ: OMER) today announced that the U.S. Food and Drug Administration (FDA) has approved YARTEMLEA® ...

Politics was not Lip-Bu Tan's priority - until Donald Trump made it one. That culminated in the most pivotal meetings of ...

A meeting with the president this year helped Intel CEO Lip-Bu Tan provide needed U.S. buy-in for the chipmaker.

Implied volatility is at multi-year lows as holiday trading suppresses premiums, but rising realized volatility hints at a ...

Hard to follow the dizzying array of developments out of Washington over the past year? Here are our answers to your pressing ...

Artificial intelligence will play a bigger role in the workplace, but McKinsey analysts believe that 2026 will be the year of ...

The iShares Bitcoin Trust ETF offers superior liquidity and institutional-grade management. Click here to read an analysis of ...

The private secondaries market just shattered records, closing 2024 at $162 billion in transactions: a 45% surge from the previous year. Yet this explosive growth masks a fundamental structural ...

The American College of Cardiology publishes new recommendations for peripheral artery disease diagnosis and treatment among adults with diabetes.

Sports media rights function as a critical link holding the entire global sports economic structure and system together – and ...

NBA trade season unofficially begins on Monday. As always, Dec. 15 is when the majority of free agents from the previous ...

After a Trump attack over China links, Intel CEO Lip-Bu Tan struck a landmark Oval Office deal, securing billions and a US ...